跳至主要内容
临床试验/JPRN-UMIN000026492
JPRN-UMIN000026492已完成未知

Intervention study of Istradefylline for the Treatment of Abnormal Posture in Patients with Parkinson's Disease - Intervention Study of Istradefylline for the Treatment of Abnormal Posture in Patients with Parkinson's Disease.

Osaka Red Cross Hospital0 个研究点目标入组 31 人开始时间: 2017年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
31

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) A score of <= 20 on the mini-mental state examination (mmse) 2) patients with abnormal posture which is not derived from parkinson's disease (e.g. compressed fracture of backbone, fracture of the pelvis, drug-induced abnormal posture) 3) patients with impact for evaluation by such treatment as deep brain stimulation transcranial magnetic stimulation or electroconvulsive therapy et cetera. 4) current use or plan to administer levodopa/carbidopa intestinal gel 5) ongoing treatment with botulinus toxin or passed treatment with botulinus toxin within 6 months 6) ongoing treatment with istradefylline or passed treatment with istradefylline within 1 year 7) moderate to severe hepatic disorder or current treatment with a strong inhibitor of cyp3a4 8) lactating, pregnant, or possibly pregnant women 9) other conditions judged by the investigator or subinvestigator to be unsuitable for participation in the research

研究者

发起方
Osaka Red Cross Hospital

相似试验